← Open Payments lookup

CHRISTOPHER PAGNANI: Open Payments

NPI 1215172374 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,497 in 72 payments from 20 companies in 2025. Trend: 2023 $891 · 2024 $984 · 2025 $1,497

Food & beverage: $1,497
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$175
Alkermes, Inc.7$152
Vanda Pharmaceuticals Inc.7$129
Tris Pharma Inc5$103
Neos Therapeutics, LP6$101
Supernus Pharmaceuticals, Inc.4$101
Lundbeck LLC4$99
Takeda Pharmaceuticals U.S.A., Inc.5$99
ABBVIE INC.4$84
Collegium Pharmaceutical, Inc.3$67

Products named: CAPLYTA, FANAPT, Dyanavel XR, Adzenys XR-ODT, Qelbree, REXULTI, TRINTELLIX, LYBALVI.

Industry payments across PA — which companies pay providers there.